Major Depressive Disorder Rosanna Scott What is MDD? DSM-5 sets 3 criteria: A 5+ symptoms present in same 2-week period, where at least one symptom is (1) depressed mood or (2) loss of interest or pleasure. The rest of the symptoms may include: • Depressed mood most of the day nearly every day. • In children/adolescents, can be irritable mood. • Diminished interest/pleasure in all or almost all activities most of the day nearly every day. • Weight loss, weight gain, decrease/increase in appetite. • In children, failure to make expected weight gain. • Insomnia/hypersomnia. • Psychomotor agitation/retardation. • Fatigue or loss of energy. • Feelings of worthlessness or excessive or inappropriate guilt. • Diminished ability to think or concentrate, or indecisiveness. • Recurrent thoughts of death, recurrent suicidal ideation, suicide attempts, or suicide plans. B • The symptoms cause clinically significant distress/impairment in social, occupational, or other important areas of functioning. C • The episode is not attributable to the physiological effects of a substance or to another medical condition. Genetics 40% heritability Secondary Features: Stressful Life Events MDD Neurobiological Substrates -HPA Axis Hyperactivity -Functional abnormalities in emotion processing, reward seeking, & emotion regulation. Temperament Neuroticism -Depressed mood -Loss of interest/ pleasure Comorbid Nonmood & Medical Conditions Associated Outcomes: Higher Mortality -weight/appetite change insomnia/hypers omnia -psychomotor change -fatigue -feelings of worthlessness or guilt -diminished ability to think/concentrate -indecisiveness -thoughts of death/suicide -irritable mood Adult to Child Translation Kovacs and Beck (1977) highlight the symptoms most often agreed on between adults and children: • (1) dysphoric mood (sadness, unhappiness), irritability, and weepiness. • (2) low self-esteem, self-depreciation, hopelessness (suicidal ideation), morbid ideas, recent poor school performance, and disturbed concentration. • (3) diminished psychomotor behavior, social withdrawal, and increased aggressiveness. • (4) fatigue, sleep problems, enuresis/encopresis, weight loss or anorexia, and somatic complaints. Adult to Child Translation • Carlson & Cantwell (1980) found you could use adult research diagnostic criteria for children over 7. • Much higher incidence rate found when children are interviewed systematically about their symptoms compared to traditional evaluation. • Masked depression: often happens when depression is comorbid w/ a different disorder--one they are initially seeking treatment for. – Attention is diverted away from the depression. • Diagnosis is missed. Masking Behaviors • Could be: – Conduct disorders (hyperactivity, delinquency, aggressiveness, irritability) – Psychological reactions – Somatic complaints (headaches, stomachaches, enuresis) – School problems (school phobia, poor performance) Prevalence • Point prevalence: .4% to 2.5% for children .4% to 8.3% for adolescents • Lifetime prevalence for adolescents: 15% to 20% No gender differences in children, 2:1 ratio of girls to boys in adolescence. (Birmaher et al. (1996). Recovery • Average length of an episode of MDD in children and adolescents was 7 to 9 months. • Approximately 90% of MDD episodes remit within two years post onset. – Birmaher et al. (1996). Suicidality • Kovacs, Goldston, & Gatsonic (1993) studied the relationship between psychiatric disorder and suicide ideation/attempt. • Depressed sample (n=142) and comparison sample (n=49). • Longitudinal study: Interviews at intake, 2, 6, and 12 months. Beyond 1 year, follow up interviews were variable. Suicidality • Results: Ss w/ affective disorder were 11x more likely to have a suicide attempt compared to rest of youths. Cost of Illness • Annual cost of depressive disorders in US is about $43 billion. – 85% attributed to MDD, including costs of treatment, absenteeism from work, losses productivity, and premature death. – 70-80% of depressed teenagers do not receive treatment. Comorbidity • 40% to 70% of depressed children and adolescents develop a comorbid disorder. • Most frequently: – Dysthymia – Anxiety disorders – Disruptive disorders – Substance abuse Anxiety Before Depression? • Some studies suggest a temporal sequence hypothesis. – Mean age for anxiety is younger than mean age for depression. – Children w/ comorbid A & D were younger when they became depressed. • Bleaker prognosis – One study shows that in children w/ comorbid A & D, 2/3 were diagnosed with A before D. • Similarly, a separate study found that about 2/3 of adolescents w/ A later developed D. – Conversely, only 6.5% of adolescents w/ D later develop A. Cole et al. (1998) • Their results support the temporal sequence hypothesis. • 3 major findings: – 1: individual differences in D & A constructs were stable over time. – 2: high lvls of children’s self-reported & of parent-reported A predicted increases in self- and parent-reported D over time. – 3: high lvls of self- and parent-reported Din children did not predict increases in A over time. Monoamine Deficiency Hypothesis • Postulates there is a deficiency in serotonin or norepinephrine neurotransmission in the brain. – Strong support: its predictive power. • Almost every compound that’s been synthesized for purpose of inhibiting NE or serotonin reuptake has been proved to be a clinically effective antidepressant. (Belmaker & Agam, 2008) Dahlstrom et al. (2000) • Based on monoamine hypothesis of depression. – Polymorphism in serotonin transporter gene is associated w/ both anxious-related personality traits and major depression – Hypothesis: alterations in seratonin transporter availability in certain regions of the brain will occur with depression. Participants: 41 drug-naïve patients. -age range: 7.7 to 17.4 years -mean age: 13.2 years First split into two groups: a.) suffering from depressive disorder n=31 b.) not suffering from depressive disorder n=10 The depressed group was split into two more groups: 1.) major depression present (n=25) 2.) other depressions present (n=6) Results -at 1h post injection, depressive Ss showed higher SERT binding ratios than nondepressed Ss. •p=.02 •No significant difference b/w depressed subgroups Hypothalamic-PituitaryCortisol Hypothesis • Abnormalities in the cortisol response to stress may underlie depression. (Belmaker & Agam, 2008) HPA Dysregulation: LopezDuran et al., (2009) • Completed two meta-analyses, computing effect sizes for different measures of cortisol in MDD children/adolescents compared to a norm group. Meta-analysis 1: Dexamethasone suppresion test •17 studies comparing MDD and non-MDD controls on post DST cortisol levels. –The pooled effect size for group differences was .57 (z = 4.18, p < .01; 95% CI .28-.86), indicating less suppression/greater cortisol levels after DST in MDD children/adolescents. Meta-analysis 2: Basal Cortisol Levels • 17 studies comparing MDD and nonMDD control group on cortisol levels at baseline (not stress induced). – The pooled effect size for group differences was .20 (z = 4.53, p < .01; 95% CI .11-.29) Amygdala Activity • Roberson-Nay et al (2006) hypothesized that there would be hyperactivity in the amygdala of MDD adolescents. – Research has shown this hyperactivity in MDD adults at resting states and when viewing evocative faces. • Results: MDD showed greater left amygdala activation (p<.001) and poorer memory performance (p=.03) in comparison to healthy control group. Temperament? • DSM-5 labels neuroticism and negative affectivity as a “well-established risk factor” for MDD. – Individuals higher in neuroticism are more likely to experience an MDD should a stressful life event occur. Interrelationship of Neuroticism, Sex, and Stressful Life events • Each increased in SD in neuroticism score carried a hazard ratio for onset of depression of 1.72 (for women alone it’s 2.09). – As level of long term contextual threat increases, hazard ratio increases. Kendler, Kuhn, & Prescott (2004) Learned Helplessness • Learned helplessness: when experience with uncontrollable events can lead to the expectation that no responses in one’s repertoire will control future outcomes. – Have a maladaptive explanatory style (MES) • Explain bad events as internal, stable, and global. – Helplessness deficits: motivational, cognitive, and emotional. • Seligman’s past research found that MES was significantly correlated w/ high depression scores. – Missing link: how do life events play into this? Seligman (1972) “In summary, experience with uncontrollable trauma typically has three basic effects: (a) animals become passive in the face of trauma, i.e., they are slower to initiate responses to alleviate trauma and may not respond at all; (b) animals are retarded at learning that their responses control trauma, i.e., if the animal makes a response which produces relief, he may have trouble "catching-on" to the response-relief contingency; and (c) animals show more stress when faced with trauma they cannot control than with equivalent controllable trauma. This maladaptive behavior appears in a variety of species including man, and over a range of tasks which require voluntary responding.” Nolen-Hoeksema, Girgus, & Seligman (1986) • Hypothesis: MES will be associated w/ higher levels of depression, lower school achievement, and higher incidences of helpless behavior in classroom. • Tested kids 3, 6, 10, and 12 months after initial assessment Nolen-Hoeksema, Girgus, & Seligman (1986) • Results: – MES reported more depression and also predicted level of depression at subsequent testing times. – Correlations: • Explanatory style w/ teacher ratings of helpless behaviors in classroom (r=-.51, p<.0002). • Test scores w/ classroom helpless behaviors (r=.64, p<.0001). • Levels of depression w/ helpless behaviors in classroom (r=.27, p<.05). • Levels of depression w/ test scores (r=-.2, p <.05). Uncontrollable Life Event Feeling Helpess/Learned Helplessness Deficits Additional Negative Effects MES Vulnerability to Depression in Future Negative Events Treatment: SSRIs • Wagner et al. (2004) compared treatment of citalopram to a placebo group. • N=178 • Mean age=12.1 years • Treatment lasted 8 weeks SSRI Results • SSRI improvement was statistically and clinically significant compared to placebo. – Effect size=2.9 SSRI vs. CBT • March et al. (2004) compared 4 treatment groups: – Fluoxetine alone – CBT alone – Fluoxetine and CBT combined – Placebo • n=429 patients, 12-17 years. • Treatment was 12 weeks long. Results • Fluoxetine + CBT was superior to placebo, fluoxetine alone, and CBT alone (p=.001, .02, .01, respectively). • Fluoxetine alone was superior to CBT alone (p=.01). • Rates of response for fluoxetine with CBT were 71.0% (95% CI, 62%-80%); fluoxetine alone, 60.6% (95% CI, 51%-70%); CBT alone, 43.2% (95% CI, 34%-52%); and placebo, 34.8% (95% CI, 26%-44%). Genetics -40% heritability -Neuroticism CBT Stressful Life Events/com orbid disorders Secondary Features: Neurobiological Substrates MDD -HPA Axis Hyperactivity -monoamine deficiency -Functional abnormalities in emotion processing, reward seeking, & emotion regulation (amygdala hyperactivity). -Depressed mood -Loss of interest/ pleasure SSRIs Maladaptive explanatory style/Learned Helplessness Associated Outcomes: -Higher Mortality -decreased performance in school -worse MDD prognosis -weight/appetite change insomnia/hypers omnia -psychomotor change -fatigue -feelings of worthlessness or guilt -diminished ability to think/concentrate -indecisiveness -thoughts of death/suicide -irritable mood References American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, D.C.: Author. Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. The New England journal of medicine, 358(1), 55-68. doi: 10.1056/nejmra073096 Birhamer, B., Ryan, N. D., Williamson, D. E., Brent, D. A., Kaufman, J., Dahl, R. E., . . . Nelson, B. (1996). Childhood and adolescent depression: a review of the past 10 years. Part 1. J Am Acad Child Adolesc Psychiatry, 35, 427-439. Carlson, G. A., & Cantwell, D. P. (1980). Unmasking masked depression in children and adolescents. The American journal of psychiatry. Cicchetti, D., & Toth, S. L. (1998). The development of depression in children and adolescents. American Psychologist, 53(2), 221-241. doi: 10.1037/0003066X.53.2.221 Cole, D.A., Peeke, L.G., Martin, J.M., Truglio,R., & Seroczynski, A.D. (1998). A longitudinal look at the relation between depression and anxiety in children and adolescents. Journal of Consulting and Clinical Psychology, 66, 451-460. Dahlström, M., Ahonen, A., Ebeling, H., Torniainen, P., Heikkilä, J., & Moilanen, I. (2000). Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents. Molecular psychiatry, 5(5), 514-522. doi: 10.1038/sj.mp.4000766 Kendler, K. S., Kuhn, J., & Prescott, C. A. (2004). The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. American Journal of Psychiatry, 161(4), 631-636. Kovacs, M. (1996). Presentation and Course of Major Depressive Disorder during Childhood and Later Years of the Life Span. Journal of the American Academy of Child & Adolescent Psychiatry, 35(6), 705-715. doi: http://dx.doi.org/10.1097/00004583-199606000-00010 Kovacs, M., & Beck, A. T. (1977). An empirical-clinical approach toward a definition of childhood depression. Depression in childhood: Diagnosis, treatment, and conceptual models, 1-25. Kovacs, M., Goldston, D., & Gatsonis, C. (1993). Suicidal behaviors and childhoodonset depressive disorders: a longitudinal investigation. Journal of the American Academy of Child & Adolescent Psychiatry, 32(1), 8-20. Lopez-Duran, N. L., Kovacs, M., & George, C. J. (2009). Hypothalamic-pituitaryadrenal axis dysregulation in depressed children and adolescents: a meta-analysis. Psychoneuroendocrinology, 34(9), 1272-1283. doi: 10.1016/j.psyneuen.2009.03.016 March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., . . . Treatment for Adolescents With Depression Study, T. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA : the journal of the American Medical Association, 292(7), 807-820. doi: 10.1001/jama.292.7.807 Nolen-Hoeksema, S., Girgus, J. S., & Seligman, M. E. (1986). Learned helplessness in children: A longitudinal study of depression, achievement, and explanatory style. Journal of Personality and Social Psychology, 51(2), 435-442. doi: 10.1037/00223514.51.2.435 Roberson-Nay, R., McClure, E. B., Monk, C. S., Nelson, E. E., Guyer, A. E., Fromm, S. J., . . . Pine, D. S. (2006). Increased Amygdala Activity During Successful Memory Encoding in Adolescent Major Depressive Disorder: An fMRI Study. Biological Psychiatry, 60(9), 966-973. doi: http://dx.doi.org/10.1016/j.biopsych.2006.02.018 Seligman, M. E. (1972). Learned helplessness. Annual review of medicine, 23, 407412. doi: 10.1146/annurev.me.23.020172.002203 Wagner, K. D., Robb, A. S., Findling, R. L., Jin, J., Gutierrez, M. M., & Heydorn, W. E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161(6), 1079-1083.